July 2024: Deprescribing guidance for hypnotic drugs

News

July 2024: Deprescribing guidance for hypnotic drugs


Guidance providing key considerations for deprescribing hypnotic drugs has been added to the formulary including information in the following scenarios: treatment initiated whilst a patient was receiving in-patient care, deprescribing of benzodiazepines and z-drugs, deprescribing melatonin in adults, and deprescribing melatonin in children.

Click here for the full guidance.

See here for other recent updates to the formulary.